Published in Arch Dermatol on December 01, 2003
Merkel cell carcinoma. World J Surg Oncol (2006) 1.33
Merkel cell carcinoma: the past, the present, and the future. J Skin Cancer (2013) 0.92
A practical update of surgical management of merkel cell carcinoma of the skin. ISRN Surg (2013) 0.89
A review of the epidemiology and treatment of Merkel cell carcinoma. Clinics (Sao Paulo) (2011) 0.89
Spinal extra-dural metastasis from Merkel cell carcinoma: a rare cause of paraplegia. Eur Spine J (2007) 0.84
Merkel cell carcinoma. Am J Clin Oncol (2013) 0.83
An unusual case of Merkel cell carcinoma. J Cancer Res Clin Oncol (2007) 0.79
Merkel cell tumor of the skin treated with localized radiotherapy: are widely negative margins required? Rare Tumors (2011) 0.77
Palliative treatment for in-transit cutaneous metastases of Merkel cell carcinoma using surface-mold computer-optimized high-dose-rate brachytherapy. Cancer J (2013) 0.76
Merkel cell carcinoma treatment with radiation: a good case despite no prospective studies. Arch Dermatol (2003) 0.75
Radiation therapy in the management of Merkel cell carcinoma: current perspectives. Expert Rev Dermatol (2011) 0.75
Radiotherapy for metastatic merkel cell carcinoma: a review of the literature. J Skin Cancer (2012) 0.75
Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol (2010) 7.29
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol (2005) 3.86
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol (2008) 2.85
Is there a role for surgery for patients with a complete clinical response after chemoradiation for esophageal cancer? An intention-to-treat case-control study. Ann Surg (2013) 2.70
Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol (2012) 2.62
Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecol Oncol (2007) 2.18
Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. J Clin Oncol (2012) 1.74
Automatic segmentation of pelvic structures from magnetic resonance images for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.43
Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO). Oncologist (2012) 1.34
Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: a literature review. Radiother Oncol (2004) 1.27
Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship? Int J Radiat Oncol Biol Phys (2011) 1.26
Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO). Cancer (2013) 1.25
Quality of life in long-term survivors of oropharynx carcinoma. Int J Radiat Oncol Biol Phys (2002) 1.23
Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene (2004) 1.17
Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 surgical procedures. Oral Oncol (2005) 1.16
Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. Radiother Oncol (2008) 1.03
Prognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy. Radiat Oncol (2012) 1.01
Primary mucosal melanoma of head and neck: prognostic value of clear margins. Laryngoscope (2006) 1.00
Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity. PLoS One (2013) 1.00
Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT inhibition in bypassing this resistance. Int J Oncol (2011) 0.99
Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection. J Surg Oncol (2007) 0.96
Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer. Int J Oncol (2013) 0.95
Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer. Radiat Oncol (2012) 0.95
A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases. Radiat Oncol (2012) 0.93
Extracranial stereotactic radiotherapy: preliminary results with the CyberKnife. Onkologie (2009) 0.92
Prognosis of hypercalcemia in aerodigestive tract cancers: study of 136 recent cases. Oral Oncol (2005) 0.91
Head and neck soft tissue sarcomas of adult: prognostic value of surgery in multimodal therapeutic approach. Oral Oncol (2004) 0.91
Pulse methylprednisolone therapy for threatening periocular haemangiomas of infancy. Acta Derm Venereol (2006) 0.91
Report of eight recent cases of locally advanced primary pulmonary artery sarcomas: failure of Doxorubicin-based chemotherapy. J Thorac Oncol (2008) 0.90
Dosimetric comparison of different treatment modalities for stereotactic radiosurgery of arteriovenous malformations and acoustic neuromas. Radiother Oncol (2012) 0.90
Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results. Radiat Oncol (2011) 0.89
Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course. Breast Cancer Res Treat (2011) 0.87
Head and neck cancer in young people: a series of 52 SCCs of the oral tongue in patients aged 35 years or less. Acta Otolaryngol (2009) 0.86
A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy. Int J Radiat Oncol Biol Phys (2012) 0.86
Palliative chemotherapy does not improve survival in metastatic esophageal cancer. Oncology (2010) 0.86
Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma. Int J Radiat Oncol Biol Phys (2005) 0.86
Congenital elephantiasis-like lymphangiomatosis of a lower limb. Acta Derm Venereol (2003) 0.86
Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients. J Am Acad Dermatol (2011) 0.85
Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102. J Clin Oncol (2007) 0.85
O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma. Invest New Drugs (2008) 0.84
Clinical outcomes after Gamma Knife surgery for idiopathic trigeminal neuralgia: review of 76 consecutive cases. J Neurosurg (2008) 0.83
Oral metronomic cyclophosphamide in elderly with metastatic melanoma. Invest New Drugs (2009) 0.83
Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking. Radiat Oncol (2013) 0.82
Proposal for size justification of expanded cohort at phase-2-recommended dose. Invest New Drugs (2010) 0.82
Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial. Target Oncol (2013) 0.82
[Frequency of genetic diseases and cancer antecedents in 493 adults with visceral or soft tissue sarcomas]. Bull Cancer (2003) 0.82
Psychosocial factors involved in delayed consultation by patients with head and neck cancer. Head Neck (2005) 0.82
Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer. Ann Surg (2013) 0.82
Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03). Radiother Oncol (2008) 0.82
Adjuvant radiation therapy in metastatic lymph nodes from melanoma. Radiat Oncol (2011) 0.82
Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever. Support Care Cancer (2004) 0.81
Inverse treatment planning for spinal robotic radiosurgery: an international multi-institutional benchmark trial. J Appl Clin Med Phys (2016) 0.81
Preservation of form and function during management of cancer of the larynx and hypopharynx. World J Surg (2003) 0.81
SHARE: a French multicenter phase III trial comparing accelerated partial irradiation versus standard or hypofractionated whole breast irradiation in breast cancer patients at low risk of local recurrence. Clin Adv Hematol Oncol (2013) 0.81
Is preoperative chemoradiation with paclitaxel and carboplatin a new standard of treatment for esophageal cancer? Int J Radiat Oncol Biol Phys (2013) 0.80
MRI definition of target volumes using fuzzy logic method for three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys (2003) 0.80
[Radiation-induced skin reactions (except malignant tumors)]. Bull Cancer (2003) 0.80
[Standards, Options and Recommendations for the management of invasive cervical cancer patients (non metastastic)]. Bull Cancer (2003) 0.80
Re: "The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: a systematic review of the literature" [Radiotherapy and Oncology 89 (2009) 245-253]. Radiother Oncol (2009) 0.80
Low dose recombinant FSH treatment may reduce multiple gestations caused by controlled ovarian hyperstimulation and intrauterine insemination. BJOG (2004) 0.79
Prognostic significance of wound infections following major head and neck cancer surgery: an open non-comparative prospective study. Support Care Cancer (2004) 0.79
Which α/β ratio and half-time of repair are useful for predicting outcomes in prostate cancer? Radiother Oncol (2010) 0.79
[A prospective evaluation of antibiotic prophylaxis efficacy for breast cancer surgery following previous chemotherapy]. Bull Cancer (2004) 0.79
Previous chemotherapy as a predictor of wound infections in nonmajor head and neck surgery: Results of a prospective study. Head Neck (2004) 0.78
Chemosensitivity of radioresistant cells in the multicellular spheroids of A549 lung adenocarcinoma. J Exp Clin Cancer Res (2009) 0.78
Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction. Anticancer Drugs (2013) 0.78
Evidence based and new developments in re-irradiation for recurrent or second primary head and neck cancers. Curr Opin Otolaryngol Head Neck Surg (2012) 0.78
Activity of the polyamine-vectorized anti-cancer drug F14512 against pediatric glioma and neuroblastoma cell lines. Invest New Drugs (2014) 0.78
[Radiotherapy promises: focus on lung cancer]. Bull Cancer (2013) 0.77
Stereotactic body radiotherapy. BMJ (2011) 0.77
MRI prostate radiation therapy planning: when the patient distorts his own image (Regarding Lambert et al., Radiother Oncol 2011; 98: 330-334). Radiother Oncol (2011) 0.77
Silicon Nanotweezers with a microfluidic cavity for the real time characterization of DNA damage under therapeutic radiation beams. Conf Proc IEEE Eng Med Biol Soc (2013) 0.77
[Reirradiation for recurrent or second primary head and neck cancers]. Bull Cancer (2011) 0.76
Concomitant Chemoradiotherapy With Image-guided Pulsed Dose Rate Brachytherapy as a Definitive Treatment Modality for Early-stage Cervical Cancer. Am J Clin Oncol (2015) 0.76
Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome. BMC Cancer (2013) 0.76
Vacuum-assisted closure therapy in the management of patients undergoing vulvectomy. Eur J Obstet Gynecol Reprod Biol (2012) 0.76
Ionizing radiation to prevent arterial intimal hyperplasia at the edges of the stent: induces necrosis and fibrosis. J Surg Res (2006) 0.76
Occult invasive cervical cancer found after inadvertent simple hysterectomy: is the ideal management: systematic parametrectomy with or without radiotherapy or radiotherapy only? Ann Surg Oncol (2014) 0.76
Reply to R. Glynne-Jones et al. J Clin Oncol (2013) 0.75
External beam ionizing radiation for inhibition of myointimal hyperplasia after dilatation and anastomoses: experimental models and results. Ann Vasc Surg (2004) 0.75
Have we established a stereotactic body radiotherapy regimen for liver metastases? J Clin Oncol (2009) 0.75
Focal HIFU for prostate cancer. Lancet Oncol (2012) 0.75
Re: Chao-Yu Hsu, Steven Joniau, Raymond Oyen et al. Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience. Eur urol 2007;51:121-9. Eur Urol (2007) 0.75
Cetuximab with concurrent chemoradiation for esophagogastric cancer: in regard to Safran et al. (Int J Radiat Oncol Biol Phys 2008;70:391-395). Int J Radiat Oncol Biol Phys (2008) 0.75
Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors. Med Oncol (2012) 0.75
External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma. Int J Radiat Oncol Biol Phys (2006) 0.75
Assessment of baseline clinical predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancer. Oncology (2008) 0.75
[Methodological approaches of clinical studies with targeted therapies]. Bull Cancer (2008) 0.75
Survival prognostic factors for lateral bucco-pharyngeal junction squamous cell carcinoma. Eur Arch Otorhinolaryngol (2007) 0.75